• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白在鼻咽癌中的表达:其与疾病临床分期的相关性。

Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease.

作者信息

Wang Hong-Han, Wang Xing-Wei, Tang Can-E

机构信息

Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital, Central-South University, Changsha City, Hunan Province, China.

出版信息

J Cancer Res Ther. 2011 Apr-Jun;7(2):138-42. doi: 10.4103/0973-1482.82926.

DOI:10.4103/0973-1482.82926
PMID:21768699
Abstract

PURPOSE

To investigate osteopontin (OPN) expression in human nasopharyngeal carcinoma (NPC) and evaluate its clinical significance in the disease.

MATERIALS AND METHODS

The expression of OPN mRNA in 44 frozen NPC tissue and 15 normal nasopharyngeal epithelium tissue (NNET) samples was examined by semi-quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). OPN protein expression in 67 paraffin-embedded NPC tissue and 21 NNET samples was detected by immunohistochemistry (IHC). In addition, OPN expression was investigated in 12 paired NPC and para-carcinoma tissue (PCT) samples by western blotting (WB). The association between the expression of OPN and the clinicopathologic parameters of NPC was evaluated.

RESULTS

Three different methods all showed that the expression of OPN mRNA or protein in NPC was significantly higher than in NNET or PCT (P = 0.000, 0.001, 0.000, respectively). After an examination by IHC, 88.1% (59/67) of NPC samples showed strong or moderate positive OPN staining and 28.6% (6/21) of NNET samples displayed a weak positive OPN staining. The staining of OPN in tumor cells was mainly localized to the cytoplasm. OPN expression in NPC was not related to patient age or sex (P > 0.05), but was significantly related to tumor size, regional lymph nodal metastasis, and NPC clinical stages (P < 0.05).

CONCLUSIONS

Our study demonstrated that OPN mRNA and protein overexpression in NPC may be important in the pathogenesis of the disease. It was strongly related to T stage, N stage and clinical stages of NPC, suggesting that OPN may be involved in NPC metastasis and progression.

摘要

目的

研究骨桥蛋白(OPN)在人鼻咽癌(NPC)中的表达情况,并评估其在该疾病中的临床意义。

材料与方法

采用半定量逆转录聚合酶链反应(qRT-PCR)检测44例冷冻鼻咽癌组织和15例正常鼻咽上皮组织(NNET)样本中OPN mRNA的表达。通过免疫组织化学(IHC)检测67例石蜡包埋鼻咽癌组织和21例NNET样本中OPN蛋白的表达。此外,采用蛋白质印迹法(WB)检测12对鼻咽癌组织和癌旁组织(PCT)样本中OPN的表达。评估OPN表达与鼻咽癌临床病理参数之间的相关性。

结果

三种不同方法均显示,鼻咽癌中OPN mRNA或蛋白的表达显著高于NNET或PCT(P值分别为0.000、0.001、0.000)。免疫组织化学检测后,88.1%(59/67)的鼻咽癌样本显示OPN染色呈强阳性或中度阳性,28.6%(6/21)的NNET样本显示OPN染色呈弱阳性。肿瘤细胞中OPN的染色主要定位于细胞质。鼻咽癌中OPN的表达与患者年龄或性别无关(P>0.05),但与肿瘤大小、区域淋巴结转移及鼻咽癌临床分期显著相关(P<0.05)。

结论

我们的研究表明,鼻咽癌中OPN mRNA和蛋白的过表达可能在该疾病的发病机制中起重要作用。它与鼻咽癌的T分期、N分期及临床分期密切相关,提示OPN可能参与鼻咽癌的转移和进展。

相似文献

1
Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease.骨桥蛋白在鼻咽癌中的表达:其与疾病临床分期的相关性。
J Cancer Res Ther. 2011 Apr-Jun;7(2):138-42. doi: 10.4103/0973-1482.82926.
2
Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.骨桥蛋白的过表达促进人鼻咽癌的细胞增殖和迁移,并与不良预后相关。
Eur Arch Otorhinolaryngol. 2018 Feb;275(2):525-534. doi: 10.1007/s00405-017-4827-x. Epub 2017 Dec 6.
3
Osteopontin promotes EZH2 expression and tumor progression in nasopharyngeal carcinoma.骨桥蛋白促进鼻咽癌中EZH2的表达及肿瘤进展。
ORL J Otorhinolaryngol Relat Spec. 2014;76(5):273-81. doi: 10.1159/000369144. Epub 2014 Nov 27.
4
Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma.骨桥蛋白是局部晚期鼻咽癌患者骨转移和生存的有用预测指标。
Int J Cancer. 2015 Oct 1;137(7):1672-8. doi: 10.1002/ijc.29540. Epub 2015 Apr 29.
5
Osteopontin regulates growth and migration of human nasopharyngeal cancer cells.骨桥蛋白调节人鼻咽癌细胞的生长和迁移。
Mol Med Rep. 2011 Nov-Dec;4(6):1169-73. doi: 10.3892/mmr.2011.538. Epub 2011 Jul 21.
6
FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.FLJ10540 与鼻咽癌的肿瘤进展相关,并通过骨桥蛋白/CD44 途径促进鼻咽癌细胞的增殖和转移。
J Transl Med. 2012 May 16;10:93. doi: 10.1186/1479-5876-10-93.
7
Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma.未分化鼻咽癌患者血浆骨桥蛋白水平升高。
Eur J Surg Oncol. 2005 Jun;31(5):555-8. doi: 10.1016/j.ejso.2005.01.005.
8
Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma.基质金属蛋白酶 14 过表达与鼻咽癌的进展和不良预后相关。
Arch Med Res. 2015 Apr;46(3):186-92. doi: 10.1016/j.arcmed.2015.03.006. Epub 2015 Mar 28.
9
CDK3 expression and its clinical significance in human nasopharyngeal carcinoma.CDK3在人鼻咽癌中的表达及其临床意义
Mol Med Rep. 2014 Jun;9(6):2582-6. doi: 10.3892/mmr.2014.2095. Epub 2014 Mar 31.
10
Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.骨桥蛋白基因多态性与鼻咽癌风险的关联。
Hum Immunol. 2014 Jan;75(1):76-80. doi: 10.1016/j.humimm.2013.09.014. Epub 2013 Oct 9.

引用本文的文献

1
SPP1 and FN1 are significant gene biomarkers of tongue squamous cell carcinoma.SPP1和FN1是舌鳞状细胞癌的重要基因生物标志物。
Oncol Lett. 2021 Oct;22(4):713. doi: 10.3892/ol.2021.12974. Epub 2021 Aug 6.
2
Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.骨桥蛋白的过表达促进人鼻咽癌的细胞增殖和迁移,并与不良预后相关。
Eur Arch Otorhinolaryngol. 2018 Feb;275(2):525-534. doi: 10.1007/s00405-017-4827-x. Epub 2017 Dec 6.
3
Expression of Osteopontin in Oral Squamous Cell Carcinoma and its Surgical Margins-An Immunohistochemical Study.
骨桥蛋白在口腔鳞状细胞癌及其手术切缘中的表达——一项免疫组织化学研究
J Clin Diagn Res. 2015 Nov;9(11):ZC66-9. doi: 10.7860/JCDR/2015/12777.6836. Epub 2015 Nov 1.
4
OPN -Revisited.骨桥蛋白 - 再探讨。
J Clin Diagn Res. 2015 Jun;9(6):ZE10-3. doi: 10.7860/JCDR/2015/12872.6111. Epub 2015 Jun 1.
5
OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC.OPN 多态性与晚期 NSCLC 的化疗反应和预后相关。
Int J Genomics. 2014;2014:846142. doi: 10.1155/2014/846142. Epub 2014 Aug 5.
6
Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study.白细胞介素4、白细胞介素6和骨桥蛋白——原发性诊断中头颈部恶性肿瘤的血清学标志物:一项初步研究。
Oncol Lett. 2014 Sep;8(3):1112-1118. doi: 10.3892/ol.2014.2312. Epub 2014 Jul 4.
7
Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.骨桥蛋白基因多态性与鼻咽癌风险的相关性。
Med Oncol. 2014 Jul;31(7):20. doi: 10.1007/s12032-014-0020-x. Epub 2014 Jun 10.
8
Role of osteopontin in the pathophysiology of cancer.骨桥蛋白在癌症病理生理学中的作用。
Matrix Biol. 2014 Jul;37:131-41. doi: 10.1016/j.matbio.2014.03.001. Epub 2014 Mar 19.
9
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.骨桥蛋白剪接变体的 mRNA 水平对软组织肉瘤患者预后的影响。
BMC Cancer. 2012 Apr 2;12:131. doi: 10.1186/1471-2407-12-131.